TANDEM DIABETES CARE INC (TNDM:NASDAQ)
$17.91 0.74 (4.3098%)
Analysed TANDEM DIABETES CARE INC (TNDM:NASDAQ) News Sources
Is Abbott Laboratories (ABT) Stock Still a Healthcare Growth Opportunity After Analyst Target Cut?
08-07-2026
yahoo.com
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Turn Down
09-07-2026
yahoo.com
DXCM Grew. The Stock Did Not. Someone Is Wrong
10-07-2026
trefis.com
Is Tandem Diabetes Care (TNDM) Undervalued Following Its Abbott Libre 3 Plus Expansion?
11-07-2026
yahoo.com
Does Libre 3 Plus Integration Expand Tandem’s Interoperability Edge And Bull Case For TNDM?
12-07-2026
yahoo.com
Unpacking Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks
16-07-2026
yahoo.com
1 Unprofitable Stock with Exciting Potential and 2 Facing Challenges
17-07-2026
yahoo.com
3 Healthcare Stocks with Questionable Fundamentals
23-07-2026
yahoo.com
3 Stocks Under $50 We Steer Clear Of
27-07-2026
yahoo.com
Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls
28-07-2026
yahoo.com
What is the current price of TANDEM DIABETES CARE INC (TNDM:NASDAQ)?
The current price of TANDEM DIABETES CARE INC (TNDM:NASDAQ) is $17.91.
TANDEM DIABETES CARE INC (TNDM:NASDAQ) absolute price change since previous trading day?
The absolute price change of TANDEM DIABETES CARE INC (TNDM:NASDAQ) since the previous trading day is $0.74.
TANDEM DIABETES CARE INC (TNDM:NASDAQ) percentage price change since previous trading day?
The percentage price change of TANDEM DIABETES CARE INC (TNDM:NASDAQ) since the previous trading day is 4.3098%.
What is the most recent average sentiment score for TANDEM DIABETES CARE INC (TNDM:NASDAQ)?
The most recent average sentiment score for TANDEM DIABETES CARE INC (TNDM:NASDAQ) is 53 out of 100.
What is the most recent average sentiment for TANDEM DIABETES CARE INC (TNDM:NASDAQ)?
The most recent sentiment for TANDEM DIABETES CARE INC (TNDM:NASDAQ) is .
SEC-8K** Filing Available For TANDEM DIABETES CARE INC (TNDM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.